Abstract
Africa continues to experience the highest infectious disease burden despite an increase in investments. These include investments in malaria, HIV/AIDS, tuberculosis, as well as in communicable diseases. The global targets are to reduce the burden of these diseases through improved surveillance, prevention of outbreaks, effective case management, elimination and eventually, eradication. Achieving these targets, however, is limited by the poor geographic descriptions of the disease burden. Of the big five infectious disease burdens, malaria is the most advanced in terms of mapping its distribution. Malaria cartography has since formed the evidence-base for the design of many national malaria control programmes. This chapter focuses on malaria as an example, demonstrating its geographical descriptions. The availability of georeferenced malaria case data whether based on prevalence or incidence indicators has been used extensively in the mapping of geographical extents at national and sub-national scales. However, routine surveillance data is emerging as a valuable methodology of tracking burden in sub-Saharan Africa. A particular focus of this chapter is the use of routine national health systems surveillance data to describe, at a fine-scale, the distribution of malaria. However, routine data can be applied to the cartographic description of other diseases beyond malaria. The methodological aspects of burden estimation from routine surveillance platforms and cartography are highlighted.
You have full access to this open access chapter, Download chapter PDF
Similar content being viewed by others
Keywords
Introduction
Thegeography of disease mapping in Africa stems back to 1951 following publication of atlas of diseases in Africa after the Second World War (Simmons et al. 1951). Historical attempts to eradicate malaria in Africa started mid-1950s during the Global Malaria Eradication Programme (GMEP) era. In the 1950s to 1960s, many African colonial governments developed crude national-level maps of malaria based on ecological zones and seasonality as part of the GMEP planning, for example, in Kenya (Butler 1959), Madagascar (Joncour 1956), Senegal (Lariviere et al. 1961), and Uganda (Mccrae 1975). The Failure of GMEP in Africa led to the resurgence of malaria through the 1970s and 1980s. Efforts to describe the geographical extent of malaria in Africa were resurrected in the 1990s. In 1996, the Mapping Malaria Risk in Africa/Atlas du Risqué de la Malaria en Afrique (MARA/ARMA), a collaboration between Africa research institutes, started to assemble data on malaria prevalence in sub-Saharan Africa (SSA) (Snow et al. 1996; Le Sueur et al. 1997). This was an initiative that started an assembly of data on malaria prevalence in Africa to used in malaria cartographic descriptions. Advances in computation and Geographic Information Systems (GIS) between the mid-1990s and 2000s has aided the development of robust malaria cartography including statistical description at national and sub-regional levels independently (Craig et al. 2007; Gemperli et al. 2006; Kazembe 2007; Noor et al. 2008, 2009, 2013b, 2014), and through the inception of the Malaria Atlas Project in the mid-2000s (Hay et al. 2004, 2008; Snow et al. 2005; Hay and Snow 2006; Guerra et al. 2007; Snow 2014).
Prevalence or incidence are two common indices that are now used frequently in the mapping of malaria (Macdonald 1950, 1957; Ray and Beljaev 1984). These indices provide epidemiological evidence of the spatial distribution of disease in the population. Prevalence represents the number of cases or infections at a given time (cross-section measure), while incidence represents the number of new cases arising over a specified period in the population (dynamic measure) (Fig. 3.1). Prevalence is usually stated as a rate (i.e. per fixed number in the population) while incidence is commonly expressed as the number of cases per 1000 population per year (Swaroop et al. 1966; Pull 1972). There are many reasons for describing the geography of these two metrics. Maps are useful tools to visualise the extent of a public health problem and for planning interventions. Maps can also be used as measurement tools to assess the impact of public health investments providing evidence on the success or failure of health interventions (Hay et al. 2013).
Since the 1990s, with advances in computation and software, maps of malaria prevalence and incidence are increasingly available at global and national scales. These maps, however, are presented with varying degrees of precision due to the wide variety of approaches used in their production. Variation in the cartographic description of prevalence and incidence in sub-Saharan Africa is also driven by the quality and quantity of data available. For malaria, countries with good surveillance systems utilise routine data without the requirement for modelling, e.g. Comoros and Sao Tome and Principe (Alegana et al. 2020). However, poor quality of the routine data require modelling to adjust for the use of health services, inconsistent data reporting, and climatic drivers of transmission. As a result, complex statistical modelling schemes have been developed for mapping disease (Diggle et al. 1998; Giorgi et al. 2015).
Model-based geostatistical (MBG) approaches combined with environmental variables (predictors) that support dynamic transmission and incidence are now used commonly to produce a gridded, fine spatial resolution estimates (Diggle et al. 1998). The advantage of MBG methods is the ability to harness the spatial and temporal dependencies in the observed data and environmental predictors. MBG also estimates the uncertainty associated with the predicted maps which are often defined in space and time. In practice, the generalised linear mixed class of models is used to connect the observed data to environmental predictors (Dalrymple et al. 2015; Alegana et al. 2016). The precision and accuracy of predictions can be evaluated via internal model parameters, or via exceedance probabilities (Giorgi et al. 2018), and by comparing to out of sample data. One source of uncertainty in passive surveillance systems such as the Health Management Information Systems (HMIS), is contributed by variation in health sector use by the population.
Several further issues impact our ability to describe the geography of disease burden. Firstly, as prevalence declines, increasingly large sampling at the community level is required. Disease biomarkers are included in surveys conducted every 3–4 years. The precision of various biomarkers in these community surveys therefore varies and may not always be optimal for monitoring and evaluation (Alegana et al. 2017). For malaria, as prevalence declines in sub-Saharan Africa, the use of surveillance through a combination of active case detection (ACD) and passive case detection (PCD) are now part of the Global Technical Strategy (WHO 2015). This method is currently used in Swaziland and a few countries in southern Africa (Hsiang et al. 2012; Dlamini et al. 2018). Reactive Case Detection (RACD) is also used during epidemics (Sturrock et al. 2013). In practice, PCD is labour intensive and is hampered by the high costs of tracking cases in the population. PCD should ideally complement the ACD approach. However, most data from PCD are unreliable and incomplete (Githinji et al. 2017). Moreover, some case data reported through this system are based on clinical examination rather than parasitology. With declining burden, the ability to identify symptomatic and asymptomatic infections is critical for control and pre-elimination programmes.
This chapter reports on the highlighted data and methodological advances in disease mapping along with the advantages of using routine data. This contribution has important implications for future research on malaria in line with a declining burden for traditionally high malaria burden countries as well as for low-transmission settings. Furthermore, emphasise that routine surveillance remains the foundation for gathering evidence, tracking progress, identifying areas for rapid response and promoting the use of data for decision making.
Disease Cartography from Routine Surveillance Systems
Role of Surveillance for Geographies of Disease
Surveillance started in the 1950s as part of GMEP and was used as a means of preventing re-emergence of disease (World Health Organization 2012a). According to the WHO, surveillance included the identification of infections, investigation, elimination of transmission and prevention as well as cure. Surveillance is a recommended intervention for tracking disease burden for targeting interventions. There are two broad areas concerned with determining the incidence of disease including the identification of cases (PCD) and elimination of the identified cases.
Introduction to Using PCD for Mapping
Innovative approaches now exist to harness PCD and, thus, complement ACD which is not yet adopted by much of sub-Saharan Africa. To properly utilise routine data, there is a need to establish the denominator, i.e. population covered by the health system (the catchment population). The methods now exist for capturing the febrile population using the healthcare system and combining this with fine spatial resolution population maps (Tatem 2014) to estimate catchment populations. Secondly, alongside improvements in HMIS data, for example, through District Health Information Systems (DHIS 2) (Karuri et al. 2014; Dehnavieh et al. 2018) statistical techniques can be used to model the spatial and temporal variability in incidence while at the same time accounting for the rate of health facility utilisation and incompleteness (Alegana et al. 2013). Such approaches incorporate ecological or environmental drivers to predict risk in receptive areas while at the same time quantifying the uncertainty associated with disease predictions (Noor et al. 2012, 2013a).
Overcoming Barriers in Mapping Using HMIS Data
Health facility data serve as indicators of the disease epidemiology amongst the populations they serve. As surveillance centres, health facilities are better barometers of changing disease landscapes than modelled snapshots of prevalence.
Despite methodological advances, HMIS data have been previously ignored for burden estimation because of incomplete reporting and variation in the population using public health sectors across sub-Saharan Africa (Battle et al. 2016; Alegana et al. 2018). This implies that cases recorded at the health facility often indicate only the ‘tip of the iceberg’ of the actual burden. This variation in utilisation potentially introduces a bias in the estimation of disease burden. In addition, weak health systems in relation to the quality and quantity of data have in the past contributed to a general lack of confidence in the use of health facility data in sub-Saharan Africa.
HMIS , however, remain an important source of data for future disease mapping for several reasons. Firstly, the spatial distribution of health facilities is usually congruent to the population distribution (Fig. 3.2). Secondly, health facility case data are often collected in an ongoing manner (e.g. daily, weekly and monthly) (Mueller et al. 2011). The implication is that data are likely to have a temporal signal useful in identifying the seasonal dynamics of the disease. Thirdly, the coverage of a health facility catchment population often encompasses several villages, communities and sometimes the whole administrative region (e.g. district). This implies a wider geographic coverage of a single health facility in an HMIS than of a single village in a cross-sectional prevalence survey.
The Geography of the Denominator for Burden Estimation
Disease estimation based on health facility data requires a definition of the denominator (febrile population within the health facility catchment population). Thus, using health facility data for mapping incidence requires an adjustment for healthcare use, both in the public and private sectors. Utilisation has in the past been estimated from household surveys by quantifying the probability of public or private sector use (Stekelenburg et al. 2005; Noor et al. 2006). Such an approach is potentially beneficial in identifying the population not covered by healthcare systems. Previously, this has been characterised in GIS by defining a distance metric (or travel times) (Apparicio and Seguin 2006; Noor et al. 2006; Apparicio et al. 2008). At the second stage, the reported rates of use at the community level are modelled as a function of travel time or distance to define a utilisation probability index (Alegana et al. 2012) (Fig. 3.3). The probabilistic estimate is useful for burden estimation because patients located far from a health facility are less likely to be treated in a formal care setting. It is then possible to estimate a population coverage indicator as well as hard catchment boundaries (e.g. for probability >40%). An example of this approach has been used in Namibia to zone catchment areas and estimate the age-structured catchment population (Alegana et al. 2016).
Environmental Drivers of Geographical Risk
Disease burden mapping generally requires a statistical model with a suitable combination of environmental variables (covariates) to predict incidence or prevalence. Several covariates have been shown to drive disease dynamics and transmission. It is important to select a biologically plausible set of covariates related to disease based on some criterion to achieve parsimony. This is because using many covariates may result in over-fitting or introduce multicollinearity (Babyak 2004). Thus, preliminary selection of a set of covariates that best describes the response is a widely accepted exercise in statistical modelling of burden (Murtaugh 2009).
For malaria mapping, environmental variables affect the development and survival of the malaria parasite as well as the malaria vector (Molineaux et al. 1988). Examples of these include the monthly rate of precipitation, temperature, vegetation cover, aridity and urbanisation (Craig et al. 1999; Guerra et al. 2008). Figure 3.4 shows an example of satellite remotely sensed covariates plotted against PCD in Eritrea. These include precipitation, minimum temperature, maximum temperature and mean temperature, the normalised difference vegetation index (NDVI) and the enhanced vegetation index (EVI). The vegetation indices are derived from MODerate-resolution Imaging Spectroradiometer (MODIS) sensor imagery; produced after removing heavy aerosols through atmospheric correction, elimination of shadows and clouds and correcting to bidirectional reflectance (Huete et al. 2002). The mean monthly gridded temperature estimates were downloaded from the WorldClim repository at approximately 1 km spatial resolution (0.000833° × 0.000833°). These gridded estimates were produced from long-term climate observations for the period 1950–2000, interpolated using smoothing spline algorithms. Precipitation data were obtained from the Tropical Rainfall Measuring Mission sensor (TRMM 3B43 product) that combines ground observations and satellite sensor data to generate gridded rainfall estimates at approximately 0.25° × 0.25° spatial resolution (Huffman et al. 2007). TRMM 3B43 is a gridded mean monthly average product of precipitation rate in mm h−1.
Example of Mapping PCD from HMIS
Spatial regression models are common in disease mapping (Bernardinelli et al. 1997; Clements et al. 2006; Schrödle and Held 2010, 2011). Two common approaches involve smoothing of disease rates in space applying small-area estimation methods (conditional autoregressive (CAR)) and the interpolation via geostatistical approaches (Banerjee et al. 2004). The CAR framework involves spatial smoothing between administrative areas (e.g. districts) (Besag et al. 1991). The level of smoothing is controlled via modelling parameters. A suitable smoothing approach should take into consideration the arrangement of spatial units to yield optimal spatial variation. A general problem common to this approach, however, relates to a change in the statistical outputs as a result of a change in the shape or size of the geographic unit, the modifiable areal unit problem (MAUP). Hierarchical modelling aims to mitigate some aspects of MAUP.
An example of the use of a hierarchical Bayesian model applied to smooth monthly malaria incidence at the district level for case data is shown based on data in Fig. 3.4. The numerator is presented as the sum of cases recorded at the facility (include both confirmed case through parasitology diagnosis and clinical diagnosis). The denominator was derived from the population-weighted catchments representing all-age febrile case risk at each health facility. An adjustment is made to clinical case diagnosis using the slide positivity rate at the facility for the numerator. For the denominator, adjustment is necessary for reporting rate and health facility use (Fig. 3.5). This modelling example was conducted using facility-level data. Thus, a facility-level random effect was incorporated to allow for variation between facilities at the district level as well as a seasonal trend. Such an approach improves smoothing and estimation. To deal with incomplete reporting missing data months were imputed as ‘NAs’. Random effects were incorporated at the district and regional levels. Non-linear parametric smoothing functions were used for the covariates rather than an assumption of linearity (constant) (Fahrmeir and Knorr-Held 2000) (Fig. 3.6).
Discussion
Routine Surveillance for Mapping Disease Burden
The chapter aimed to highlight issues around the use of these data in SSA , challenges and examples of methods deployed to map routine surveillance data. HMIS coordinates the routine acquisition of data from health facilities (public and private) and compilation of these data (e.g. cases) through the district, regional and national levels (Abouzahr et al. 2007; Boerma and Stansfield 2007). Such data form an integral part of healthcare delivery and are useful for planning, resource allocation and disease monitoring. In reality, however, HMIS are often incomplete in many African countries as outlined in this chapter and the utilisation of health facilities is not uniform. Some of the factors contributing to low facility utilisation include the availability of health services, financial factors, geographic access and waiting times at facilities (Breman 2001). Studies carried out in Kenya suggested cost, distance and opening times as some of the main factors influencing choice and decisions to seek treatment in either the public or private sector (Chuma et al. 2010) impacting data on cases recorded at the health facility and within HMIS. Therefore, specific methods using surveillance data to produce disease cartography are necessary to smooth estimates of incidence and adjust for sporadic reporting and utilisation by the population. These were demonstrated in this chapter alongside accounting for environmental variables when estimating incidence. Mapping disease incidence is important to the various national health programmes for resource allocation and provides useful insights in carrying out targeted surveillance.
Geographies of Disease Burden in Low-Transmission Settings
The declining prevalence of disease presents several challenges. With low transmission, the disease tends to cluster in specific population ‘hotspots’ (Bousema et al. 2012, 2016). The traditional household surveys become challenging to implement because of the requirement for large sampling and cross-sectional surveys fail to detect short-term changes in disease prevalence (at small temporal scales). This is because cases vary temporally, being susceptible to changes in climate, ecology and population movements (Erbach-Schoenberg et al. 2016). The cartographic challenge is then to identify hotspots of transmission at fine spatial resolution based on the aggregated case data observed passively or combined with active case detection. Approaches to mapping disease based on cases aggregated at the district level and prediction of spatio-temporal maps at a fine spatial resolution can be used (Alegana et al. 2016) (Fig. 3.7). The approach improves the ability to characterise hotspots at the fine spatial resolution and can be used to target resources to specific local populations. This targeting can be cost-effective where the population distribution is sparse and further surveillance can be limited to specific local areas.
Challenges and Opportunities for Cartography for Elimination
Progress in identifying symptomatic cases within the population has important implications for asymptomatic case detection. Both PACD and RACD will benefit from the improved mapping of passively detected cases at fine spatial resolution. Improvement in routine data quality is likely to enhance malaria cartography. A different challenge exists in areas where multiple malaria parasites co-infect (Cotter et al. 2013). Most of the approaches outlined for disease cartography often focus on one parasite species. For example, there has been some progress in mapping other malaria parasites on the continent such as P. vivax (Battle et al. 2019). There is increasing evidence of Pv distribution (Twohig et al. 2019). More effective approaches need to be developed for mapping co-infections (Commons et al. 2019). The challenges posed by P. vivax are considerable due to the biological characteristics (Mueller et al. 2009). P. vivax exhibits a dormant liver stage responsible for most relapses up to weeks or months after an initial attack (White 2011). This complicates the ability to detect and apply suitable cartographic approaches to the asymptomatic Pf and Pv co-infections within the population.
Conclusion
The last decade has seen a transformation in Health Management Information System (HMIS) data in Africa. Two key advances include data digitisation of data through DHIS2 and Firstly, the ability to define malaria-specific morbidity presenting to the health facilities through Test. Treat. Track (T3) initiative (World Health Organization 2012b). The potential benefit of this transformation cannot be over-stated since the data represent the entirety of the presenting cases in national public health systems in participating African countries. Moreover, most African nations now have operational digital and georeferenced HMIS, meaning that the ensemble of HMIS represents a powerful lens through which to assess the health of the people of Africa as a whole. The data are subject to some biases, most notably that the public health system is only a part of the full health system, albeit a major part and that under-utilisation of the health system can occur at alarming rates, particularly in rural areas. Nevertheless, Bayesian statistical approaches have been developed by the authors that allow for suppression of these biases when mapping disease incidence through space and time. With appropriate Bayesian statistical handling, including the use of environmental covariates, the HMIS data have great potential for monitoring the health of Africa over space and time and for targeting interventions in both space and time. They have a particular utility for low endemicity settings, or in pre-elimination settings, where prevalence of disease is low and clustered in hotspots. In such settings, active case detection is extremely inefficient to the point of being unusable, and passive case detection, as afforded by the HMIS, can be invaluable for residual or emerging hotspot detection. We hope that this chapter will lead to greater awareness of the potential of African HMIS for and the space-time statistical techniques that allow their proper and principled use.
References
Abouzahr, C., Adjei, S., & Kanchanachitra, C. (2007). From data to policy: Good practices and cautionary tales. The Lancet, 369, 1039–1046.
Alegana, V., Wright, J., Petrina, U., Noor, A., Snow, R., & Atkinson, P. (2012). Spatial modelling of healthcare utilisation for treatment of fever in Namibia. International Journal of Health Geographics, 11, 6.
Alegana, V. A., Atkinson, P. M., Wright, J. A., Kamwi, R., Uusiku, P., Katokele, S., Snow, R. W., & Noor, A. M. (2013). Estimation of malaria incidence in northern Namibia in 2009 using Bayesian conditional-autoregressive spatial-temporal models. Spatial and Spatio-temporal Epidemiology, 7, 25–36.
Alegana, V. A., Atkinson, P. M., Lourenço, C., Ruktanonchai, N. W., Bosco, C., Erbach-Schoenberg, E. Z., Didier, B., Pindolia, D., Le Menach, A., Katokele, S., et al. (2016). Advances in mapping malaria for elimination: Fine resolution modelling of Plasmodium falciparum incidence. Scientific Reports, 6, 29628.
Alegana, V. A., Wright, J., Bosco, C., Okiro, E. A., Atkinson, P. M., Snow, R. W., Tatem, A. J. & Noor, A. M. (2017). Malaria prevalence metrics in low- and middle-income countries: an assessment of precision in nationally-representative surveys. Malaria Journal, 16, 475.
Alegana, V. A., Maina, J., Ouma, P. O., Macharia, P. M., Wright, J., Atkinson, P. M., Okiro, E. A., Snow, R. W., & Tatem, A. J. (2018). National and sub-national variation in patterns of febrile case management in sub-Saharan Africa. Nature Communications, 9, 4994.
Alegana, V. A., Okiro, E. A., & Snow, R. W. (2020). Routine data for malaria morbidity estimation in Africa: Challenges and prospects. BMC Medicine, 18, 121.
Apparicio, P., & Seguin, A.-M. (2006). Measuring the accessibility of services and facilities for residents of public housing in Montreal. Urban Studies, 43, 187–211.
Apparicio, P., Abdelmajid, M., Riva, M., & Shearmur, R. (2008). Comparing alternative approaches to measuring the geographical accessibility of urban health services: Distance types and aggregation-error issues. International Journal of Health Geographics, 7, 7.
Babyak, M. A. (2004). What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine, 66, 411–421.
Banerjee, S., Carling, P. B., & Gelfand, A. E. (2004). Hierarchical modeling and analysis for spatial data. London: Chapman & Hall/CRC.
Battle, K. E., Bisanzio, D., Gibson, H. S., Bhatt, S., Cameron, E., Weiss, D. J., Mappin, B., Dalrymple, U., Howes, R. E., Hay, S. I., et al. (2016). Treatment-seeking rates in malaria endemic countries. Malaria Journal, 15, 1–11.
Battle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., et al. (2019). Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: A spatial and temporal modelling study. The Lancet, 394, 332–343.
Bernardinelli, L., Pascutto, C., Best, N. G., & Gilks, W. R. (1997). Disease mapping with errors in covariates. Statistics in Medicine, 16, 741–752.
Besag, J., York, J., & Mollie, A. (1991). Bayesian image restoration, with two applications in spatial statistics. Annals of the Institute of Statistical Mathematics, 43, 1–59.
Boerma, J. T., & Stansfield, S. K. (2007). Health statistics now: Are we making the right investments? The Lancet, 369, 779–786.
Bousema, T., Griffin, J. T., Sauerwein, R. W., Smith, D. L., Churcher, T. S., Takken, W., Ghani, A., Drakeley, C., & Gosling, R. (2012). Hitting hotspots: Spatial targeting of malaria for control and elimination. PLoS Medicine, 9, e1001165.
Bousema, T., Stresman, G., Baidjoe, A. Y., Bradley, J., Knight, P., Stone, W., Osoti, V., Makori, E., Owaga, C., Odongo, W., et al. (2016). The impact of hotspot-targeted interventions on malaria transmission in Rachuonyo South District in the Western Kenyan highlands: A cluster-randomized controlled trial. PLoS Medicine, 13, e1001993.
Breman, J. G. (2001). The ears of the hippopotamus: Manifestations, determinants, and estimates of the malaria burden. The American Journal of Tropical Medicine and Hygiene, 64, 1–11.
Butler, R. (1959). Atlas of Kenya: A comprehensive series of new and authenticated maps prepared from the national survey and other governmental sources with gazetteer and notes on pronunciations and spelling. Nairobi: Survey of Kenya.
Chuma, J., Okungu, V., & Molyneux, C. (2010). Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Malaria Journal, 9, 144.
Clements, A. C., Lwambo, N. J., Blair, L., Nyandindi, U., Kaatano, G., Kinung'hi, S., Webster, J. P., Fenwick, A., & Brooker, S. (2006). Bayesian spatial analysis and disease mapping: Tools to enhance planning and implementation of a schistosomiasis control programme in Tanzania. Tropical Medicine & International Health, 11, 490–503.
Commons, R. J., Simpson, J. A., Thriemer, K., Hossain, M. S., Douglas, N. M., Humphreys, G. S., Sibley, C. H., Guerin, P. J., & Price, R. N. (2019). Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: A systematic review and meta-analysis. The Lancet Infectious Diseases, 19, 91–101.
Cotter, C., Sturrock, H. J. W., Hsiang, M. S., Liu, J., Phillips, A. A., Hwang, J., Gueye, C. S., Fullman, N., Gosling, R. D., & Feachem, R. G. A. (2013). The changing epidemiology of malaria elimination: New strategies for new challenges. The Lancet, 382, 900–911.
Craig, M. H., Snow, R. W., & Le Sueur, D. (1999). A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitology Today, 15, 105–111.
Craig, M. H., Sharp, B. L., Mabaso, M. L. & Kleinschmidt, I. (2007). Developing a spatial-statistical model and map of historical malaria prevalence in Botswana using a staged variable selection procedure. Int J Health Geogr, 6, 44.
Dalrymple, U., Mappin, B., & Gething, P. (2015). Malaria mapping: Understanding the global endemicity of falciparum and vivax malaria. BMC Medicine, 13, 140.
Dehnavieh, R., Haghdoost, A., Khosravi, A., Hoseinabadi, F., Rahimi, H., Poursheikhali, A., Khajehpour, N., Khajeh, Z., Mirshekari, N., Hasani, M., et al. (2018). The District Health Information System (DHIS2): A literature review and meta-synthesis of its strengths and operational challenges based on the experiences of 11 countries. Health Information Management Journal, 48, 62–75.
Diggle, P., Tawn, J., & Moyeed, R. (1998). Model-based geostatistics. Applied Statistics, 47, 229–350.
Dlamini, N., Zulu, Z., Kunene, S., Geoffroy, E., Ntshalintshali, N., Owiti, P., Sikhondze, W., Makadzange, K., & Zachariah, R. (2018). From diagnosis to case investigation for malaria elimination in Swaziland: Is reporting and response timely? Public Health Action, 8, S8–S12.
Erbach-Schoenberg, E. Z., Alegana, V. A., Sorichetta, A., Linard, C., Lourenço, C., Ruktanonchai, N. W., Graupe, B., Bird, T. J., Pezzulo, C., Wesolowski, A., et al. (2016). Dynamic denominators: The impact of seasonally varying population numbers on disease incidence estimates. Population Health Metrics, 14, 35.
Fahrmeir, L., & Knorr-Held, L. (2000). Dynamic and semiparametric models. In Smoothing and regression. New York: John Wiley & Sons.
Gemperli, A., Vounatsou, P., Sogoba, N. & Smith, T. (2006). Malaria Mapping Using Transmission Models: Application to Survey Data from Mali. American Journal of Epidemiology, 163, 289–297.
Giorgi, E., Sesay, S. S. S., Terlouw, D. J., & Diggle, P. J. (2015). Combining data from multiple spatially referenced prevalence surveys using generalized linear geostatistical models. Journal of the Royal Statistical Society: Series A (Statistics in Society), 178, 445–464.
Giorgi, E., Osman, A. A., Hassan, A. H., Ali, A. A., Ibrahim, F., Amran, J. G. H., Noor, A. M., & Snow, R. W. (2018). Using non-exceedance probabilities of policy-relevant malaria prevalence thresholds to identify areas of low transmission in Somalia. Malaria Journal, 17, 88.
Githinji, S., Oyando, R., Malinga, J., Ejersa, W., Soti, D., Rono, J., Snow, R. W., Buff, A. M., & Noor, A. M. (2017). Completeness of malaria indicator data reporting via the District Health Information Software 2 in Kenya, 2011–2015. Malaria Journal, 16, 344.
Guerra, C., Hay, S., Lucioparedes, L., Gikandi, P., Tatem, A., Noor, A., & Snow, R. (2007). Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project. Malaria Journal, 6, 17.
Guerra, C. A., Gikandi, P. W., Tatem, A. J., Noor, A. M., Smith, D. L., Hay, S. I., & Snow, R. W. (2008). The limits and intensity of Plasmodium falciparum transmission: Implications for malaria control and elimination worldwide. PLoS Medicine, 5, e38.
Hay, S. I., & Snow, R. W. (2006). The malaria Atlas Project: Developing global maps of malaria risk. PLoS Medicine, 3, e473.
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004). The global distribution and population at risk of malaria: Past, present, and future. The Lancet Infectious Diseases, 4, 327–336.
Hay, S. I., Smith, D. L., & Snow, R. W. (2008). Measuring malaria endemicity from intense to interrupted transmission. The Lancet Infectious Diseases, 8, 369–378.
Hay, S. I., Battle, K. E., Pigott, D. M., Smith, D. L., Moyes, C. L., Bhatt, S., Brownstein, J. S., Collier, N., Myers, M. F., George, D. B. & Gething, P. W. (2013). Global mapping of infectious disease. Philosophical Transactions of the Royal Society B: Biological Sciences, 368.
Hsiang, M. S., Hwang, J., Kunene, S., Drakeley, C., Kandula, D., Novotny, J., Parizo, J., Jensen, T., Tong, M., Kemere, J., et al. (2012). Surveillance for malaria elimination in Swaziland: A national cross-sectional study using pooled PCR and serology. PLoS One, 7, e29550.
Huete, A., Didan, K., Miura, T., Rodriguez, E. P., Gao, X. & Ferreira, L. G. (2002). Overview of the radiometric and biophysical performance of the MODIS vegetation indices. Remote Sensing of Environment, 83, 195–213.
Huffman, G. J., Bolvin, D. T., Nelkin, E. J., Wolff, D. B., Adler, R. F., Gu, G., Hong, Y., Bowman, K. P. & Stocker, E. F. (2007). The TRMM Multisatellite Precipitation Analysis (TMPA): Quasi-Global, Multiyear, Combined-Sensor Precipitation Estimates at Fine Scales. Journal of Hydrometeorology, 8, 38–55.
Joncour, G. (1956). La lutte contre le paludisme a Madagascar. Bulletin of the World Health Organization (pp. 711–723).
Karuri, J., Waiganjo, P., & Manya, A. (2014). DHIS2: The tool to improve health data demand and use in Kenya. Journal of Health Informatics in Developing Countries, 8. Retrieved from https://www.jhidc.org/index.php/jhidc/article/view/113.
Kazembe, L. N. (2007). Spatial modelling and risk factors of malaria incidence in northern Malawi. Acta Tropica, 102, 126–137.
Lariviere, M., Hocquet, P., & Abonnenc, E. (1961). Résultats d’une enquête palustre dans la république du Sénégal. Indices plasmodiques chez les enfants en milieu rural. Bulletin de la Société Médicale d’Afrique Noire de Langue Française (pp. 386–403).
Le Sueur, D., Binka, F., Lengeler, C., De Savigny, D., Snow, B., Teuscher, T., & Toure, Y. (1997). An atlas of malaria in Africa. Africa Health, 19, 23–24.
Macdonald, G. (1950). The analysis of malaria parasite rates in infants. Tropical Diseases Bulletin, 47, 915–938.
Macdonald, G. (1957). The epidemiology and control of malaria. London: Oxford University Press.
Maina, J., Ouma, P. O., Macharia, P. M., Alegana, V. A., Mitto, B., Fall, I. S., Noor, A. M., Snow, R. W., & Okiro, E. A. (2019). A spatial database of health facilities managed by the public health sector in sub Saharan Africa. Scientific Data, 6, 134.
Mccrae, A. (Ed.). (1975). Uganda atlas of disease distribution. Nairobi: East African Publishing House.
Molineaux, L., Muir, D. A., Spencer, H. C., & Wernsdorfer, W. H. (1988). The epidemiology of malaria and its measurement. In W. H. Wernsdorfer & I. Mcgregor (Eds.), Malaria: Principles and practice of malariology. London: Churchill Livingstone.
Mueller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & Del Portillo, H. A. (2009). Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. The Lancet Infectious Diseases, 9, 555–566.
Mueller, I., Slutsker, L., & Tanner, M. (2011). Estimating the burden of malaria: The need for improved surveillance. PLoS Medicine, 8, e1001144.
Murtaugh, P. A. (2009). Performance of several variable-selection methods applied to real ecological data. Ecology Letters, 12, 1061–1068.
Noor, A. M., Amin, A. A., Gething, P. W., Atkinson, P. M., Hay, S. I., & Snow, R. W. (2006). Modelling distances travelled to government health services in Kenya. Tropical Medicine & International Health, 11, 188–196.
Noor, A., Clements, A., Gething, P., Moloney, G., Borle, M., Shewchuk, T., Hay, S., & Snow, R. (2008). Spatial prediction of Plasmodium falciparum prevalence in Somalia. Malaria Journal, 7, 159.
Noor, A. M., Gething, P. W., Alegana, V. A., Patil, A. P., Hay, S. I., Muchiri, E., Juma, E., & Snow, R. W. (2009). The risks of malaria infection in Kenya in 2009. BMC Infectious Diseases, 9, 180.
Noor, A. M., Alegana, V. A., Patil, A. P., Moloney, G., Borle, M., Yusuf, F., Amran, J., & Snow, R. W. (2012). Mapping the receptivity of malaria risk to plan the future of control in Somalia. BMJ Open, 2, e001160.
Noor, A., Uusiku, P., Kamwi, R., Katokele, S., Ntomwa, B., Alegana, V., & Snow, R. (2013a). The receptive versus current risks of Plasmodium falciparum transmission in northern Namibia: Implications for elimination. BMC Infectious Diseases, 13, 184.
Noor, A. M., Alegana, V. A., Kamwi, R. N., Hansford, C. F., Ntomwa, B., Katokele, S., & Snow, R. W. (2013b). Malaria control and the intensity of Plasmodium falciparum transmission in Namibia 1969–1992. PLoS One, 8, e63350.
Noor, A. M., Kinyoki, D. K., Mundia, C. W., Kabaria, C. W., Mutua, J. W., Alegana, V. A., Fall, I. S., & Snow, R. W. (2014). The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: A spatial and temporal analysis of transmission intensity. The Lancet, 383, 1739–1747.
Pull, J. H. (1972). Malaria surveillance methods, their uses and limitations. The American Journal of Tropical Medicine and Hygiene, 21, 651–657.
Ray, A. P., & Beljaev, A. E. (1984). Epidemiological surveillance: A tool for assessment of malaria and its control. The Journal of Communicable Diseases, 16, 197–207.
Schrödle, B., & Held, L. (2010). A primer on disease mapping and ecological regression using INLA. Computational Statistics, 26, 241–258.
Schrödle, B., & Held, L. (2011). Spatio-temporal disease mapping using INLA. Environmetrics, 22, 725–734.
Simmons, J. S., Whayne, T. F., Anderson, G. W., Division, U. S. S.-G. S. O. P. M., Service, U. S. S.-G. S. O. P. M. & Horack, H. M. 1951. Global Epidemiology: A Geography of Disease and Sanitation, J.B. Lippincott.Â
Snow, R. (2014). Sixty years trying to define the malaria burden in Africa: Have we made any progress? BMC Medicine, 12, 227.
Snow, R., Marsh, K., & Lesueur, D. (1996). The need for maps of transmission intensity to guide malaria control in Africa. Parasitology Today, 12, 455–457.
Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y., & Hay, S. I. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, 434, 214–217.
Stekelenburg, J., Jager, B. E., Kolk, P. R., Westen, E. H. M. N., Kwaak, A. V. D., & Wolffers, I. N. (2005). Health care seeking behaviour and utilisation of traditional healers in Kalabo, Zambia. Health Policy, 71, 67–81.
Sturrock, H. J., Novotny, J. M., Kunene, S., Dlamini, S., Zulu, Z., Cohen, J. M., Hsiang, M. S., Greenhouse, B., & Gosling, R. D. (2013). Reactive case detection for malaria elimination: Real-life experience from an ongoing program in Swaziland. PLoS One, 8, e63830.
Swaroop, S., Gilroy, A. B., & Uemura, K. (1966). Statistical methods in malaria eradication. Monograph Series. World Health Organization, 51, 1–164.
Tatem, A. J. (2014). Mapping the denominator: Spatial demography in the measurement of progress. International Health, 6, 153–155.
Twohig, K. A., Pfeffer, D. A., Baird, J. K., Price, R. N., Zimmerman, P. A., Hay, S. I., Gething, P. W., Battle, K. E., & Howes, R. E. (2019). Growing evidence of Plasmodium vivax across malaria-endemic Africa. PLoS Neglected Tropical Diseases, 13, e0007140.
White, N. (2011). Determinants of relapse periodicity in Plasmodium vivax malaria. Malaria Journal, 10, 297.
WHO. (2015). Global technical strategy for malaria 2016–2030. Geneva: WHO.
World Health Organization. (2012a). Disease surveillance for malaria control: An operational manual. Geneva: World Health Organization.
World Health Organization. (2012b). Test. Treat. Track. Scaling up diagnostic testing, treatment and surveillance for malaria. Geneva: World Health Organization.
Acknowledgements
Funding statement: Victor Alegana is funded through a Wellcome Trust Training Fellowship (#211208).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Copyright information
© 2021 The Author(s)
About this chapter
Cite this chapter
Alegana, V.A., Atkinson, P.M. (2021). Geography of Disease Burden: Case Studies in Namibia and Eritrea. In: Makanga, P.T. (eds) Practicing Health Geography. Global Perspectives on Health Geography. Springer, Cham. https://doi.org/10.1007/978-3-030-63471-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-63471-1_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63470-4
Online ISBN: 978-3-030-63471-1
eBook Packages: HistoryHistory (R0)